It appears you don't have support to open PDFs in this web browser. To view this file, Open with your PDF reader
Abstract
Aims
Heart failure with preserved ejection fraction (HFpEF) is a heterogeneous syndrome with various causes that may influence prognosis.
Methods and results
We extracted the electronic medical records for 2180 consecutive patients hospitalized between 2016 and 2019 for decompensated heart failure. Using a text mining algorithm looking for a left ventricular ejection fraction ≥50% and plasma brain natriuretic peptide level >100 pg/mL, we identified 928 HFpEF patients. We screened for a prevailing cause of HFpEF according to European guidelines and found that 418 (45.0%) patients had secondary HFpEF due to either myocardial (n = 125, 13.5%) or loading condition abnormalities (n = 293, 31.5%), while the remaining 510 (55.0%) patients had idiopathic HFpEF. We assessed the association between the causes of HFpEF and survival collected up to 31 December 2020 using Cox proportional hazards analysis. Even though patients with idiopathic HFpEF were older, frequently female, and had frequent co‐morbidities and a higher crude mortality rate compared with secondary HFpEF patients, their prognosis was similar after adjustment for age and sex. Unsupervised clustering analysis revealed three main phenogroups with different distribution of idiopathic vs. secondary HFpEF. The phenogroup with the highest proportion of idiopathic HFpEF (69%) had (i) an excess rate of non‐cardiac co‐morbidities including chronic obstructive pulmonary disease (31%) or obesity (41%) and (ii) a better prognosis compared with the two other phenogroups enriched with secondary HFpEF.
Conclusions
Aetiological classification provides clinical and prognostic information and may be useful to better decipher the clinical heterogeneity of HFpEF.
You have requested "on-the-fly" machine translation of selected content from our databases. This functionality is provided solely for your convenience and is in no way intended to replace human translation. Show full disclaimer
Neither ProQuest nor its licensors make any representations or warranties with respect to the translations. The translations are automatically generated "AS IS" and "AS AVAILABLE" and are not retained in our systems. PROQUEST AND ITS LICENSORS SPECIFICALLY DISCLAIM ANY AND ALL EXPRESS OR IMPLIED WARRANTIES, INCLUDING WITHOUT LIMITATION, ANY WARRANTIES FOR AVAILABILITY, ACCURACY, TIMELINESS, COMPLETENESS, NON-INFRINGMENT, MERCHANTABILITY OR FITNESS FOR A PARTICULAR PURPOSE. Your use of the translations is subject to all use restrictions contained in your Electronic Products License Agreement and by using the translation functionality you agree to forgo any and all claims against ProQuest or its licensors for your use of the translation functionality and any output derived there from. Hide full disclaimer
Details
; Wack, Maxime 2 ; Livrozet, Marine 1 ; Carves, Jean‐Baptiste 3
; Domengé, Orianne 4
; Vermersch, Eva 4
; Mirabel, Mariana 4 ; Karras, Alexandre 5
; Le Guen, Julien 6 ; Blanchard, Anne 1
; Azizi, Michel 7 ; Amar, Laurence 7
; Bories, Marie‐Cécile 8 ; Mousseaux, Elie 9
; Carette, Claire 10
; Puymirat, Etienne 8
; Hagège, Albert 8
; Jannot, Anne‐Sophie 2
; Hulot, Jean‐Sébastien 1
1 Université de Paris, INSERM, PARCC, Paris, France, CIC1418 and DMU CARTE, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France
2 Centre de Recherche des Cordeliers, Sorbonne Université, Université de Paris, Inserm, Paris, France, Departement d'Informatique Hospitalière, DMU PRIME, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France
3 CIC1418 and DMU CARTE, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France
4 Université de Paris, INSERM, PARCC, Paris, France
5 Université de Paris, INSERM, PARCC, Paris, France, Department of Nephrology, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France
6 Department of Geriatry, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France
7 Université de Paris, INSERM, PARCC, Paris, France, Hypertension Department and DMU CARTE, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France
8 Université de Paris, INSERM, PARCC, Paris, France, Department of Cardiology and DMU CARTE, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France
9 Université de Paris, INSERM, PARCC, Paris, France, Department of Radiology, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France
10 CIC1418 and DMU CARTE, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France, Department of Nutrition, Assistance Publique—Hôpitaux de Paris (AP‐HP), Hôpital Européen Georges‐Pompidou, Paris, France





